Johnson & Johnson (JNJ) Payables (2009 - 2026)

Johnson & Johnson (JNJ) posted Payables of $27.9 billion for Q1 2026, up 36.29% sequentially from $20.5 billion in Q4 2025, and up 19.1% YoY from $23.4 billion in Q1 2025.

Johnson & Johnson (JNJ) Payables (2009 - 2026) Analysis & Trends

Johnson & Johnson (JNJ) has 18 years of Payables data on file, last reported at $27.9 billion in Q1 2026.

  • Quarterly Payables rose 19.1% year-over-year to $27.9 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $27.9 billion (up 19.1% YoY) and the FY2025 annual result came in at $20.5 billion, up 25.73% from the prior year.
  • Payables rose to $27.9 billion in Q1 2026 per JNJ's latest filing, from $20.5 billion in the prior quarter.
  • The five-year high for Payables was $27.9 billion in Q1 2026, with the low at $12.2 billion in Q4 2023.
  • Average Payables over 5 years is $18.3 billion, with a median of $16.5 billion recorded in 2024.
  • The widest YoY moves for Payables: up 104.97% in 2023, down 42.23% in 2023.
  • Johnson & Johnson's Payables stood at $14.6 billion in 2022, then dropped by 10.25% to $13.1 billion in 2023, then gained by 24.54% to $16.3 billion in 2024, then advanced by 25.73% to $20.5 billion in 2025, then jumped by 36.29% to $27.9 billion in 2026.
  • Business Quant data shows JNJ's Payables at $27.9 billion in Q1 2026, $20.5 billion in Q4 2025, and $16.0 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 5.03 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 27.92 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 33.77 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -22.55 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 6.01 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 2.94 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 645.00 Mn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 4.51 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn 358.50 Mn

Historic Data

Download Data
DateValue
Mar 29, 2026 27.92 Bn
Dec 28, 2025 20.49 Bn
Sep 28, 2025 16.01 Bn
Jun 29, 2025 20.99 Bn
Mar 30, 2025 23.44 Bn
Dec 29, 2024 16.29 Bn
Sep 29, 2024 13.42 Bn
Jun 30, 2024 18.70 Bn
Mar 31, 2024 16.72 Bn
Dec 31, 2023 13.08 Bn
Oct 1, 2023 12.23 Bn
Jul 2, 2023 22.14 Bn
Apr 2, 2023 27.89 Bn
Jan 1, 2023 22.65 Bn
Oct 2, 2022 14.58 Bn
Jul 3, 2022 14.07 Bn
Apr 3, 2022 13.61 Bn
Jan 2, 2022 14.82 Bn
Oct 3, 2021 12.76 Bn
Jul 4, 2021 11.88 Bn